Education
About Us
Working with TipRanks
Follow Us
Chordate Medical Holding AB (SE:CMH)
:CMH
Total Valuation
Chordate Medical Holding AB has a market cap or net worth of kr18.09M. The enterprise value is -kr2.35M.
Market Capkr18.09M
Enterprise Value-kr2.35M
Share Statistics
Chordate Medical Holding AB has 2,699,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,699,620
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Chordate Medical Holding AB’s return on equity (ROE) is -2.96 and return on invested capital (ROIC) is -298.47%.
Return on Equity (ROE)-2.96
Return on Assets (ROA)-1.55
Return on Invested Capital (ROIC)-298.47%
Return on Capital Employed (ROCE)-2.98
Revenue Per Employee221.56K
Profits Per Employee-9.08M
Employee Count3
Asset Turnover0.04
Inventory Turnover-0.75
Valuation Ratios
The current PE Ratio of Chordate Medical Holding AB is ―. Chordate Medical Holding AB’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.00
Price to FCF0.00
Price to Operating Cash Flow-0.52
PEG Ratio―
Income Statement
In the last 12 months, Chordate Medical Holding AB had revenue of 664.69K and earned -27.25M in profits. Earnings per share was -26.60.
Revenue664.69K
Gross Profit1.99M
Operating Income-27.45M
Pretax Income-27.25M
Net Income-27.25M
EBITDA-25.23M
Earnings Per Share (EPS)-26.60
Cash Flow
In the last 12 months, operating cash flow was -24.55M and capital expenditures -2.30M, giving a free cash flow of -26.84M billion.
Operating Cash Flow-24.55M
Free Cash Flow-26.84M
Free Cash Flow per Share-9.94
Dividends & Yields
Chordate Medical Holding AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change-70.49%
50-Day Moving Average6.65
200-Day Moving Average9.09
Relative Strength Index (RSI)47.46
Average Volume (3m)3.14K
Important Dates
Chordate Medical Holding AB upcoming earnings date is Aug 29, 2025, TBA (Confirmed).
Last Earnings DateMay 23, 2025
Next Earnings DateAug 29, 2025
Ex-Dividend Date―
Financial Position
Chordate Medical Holding AB as a current ratio of 0.92, with Debt / Equity ratio of 0.00%
Current Ratio0.92
Quick Ratio0.71
Debt to Market Cap0.00
Net Debt to EBITDA0.10
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Chordate Medical Holding AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Chordate Medical Holding AB EV to EBITDA ratio is -0.26, with an EV/FCF ratio of -0.24.
EV to Sales10.04
EV to EBITDA-0.26
EV to Free Cash Flow-0.24
EV to Operating Cash Flow-0.27
Balance Sheet
Chordate Medical Holding AB has kr12.85M in cash and marketable securities with ― in debt, giving a net cash position of -kr12.85M billion.
Cash & Marketable Securitieskr12.85M
Total Debt―
Net Cash-kr12.85M
Net Cash Per Share-kr4.76
Tangible Book Value Per Sharekr1.27
Margins
Gross margin is -419.95%, with operating margin of -4129.04%, and net profit margin of -4100.21%.
Gross Margin-419.95%
Operating Margin-4129.04%
Pretax Margin-4100.21%
Net Profit Margin-4100.21%
EBITDA Margin-3795.21%
EBIT Margin-4129.04%
Analyst Forecast
The average price target for Chordate Medical Holding AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―